Metoprolol effect on heart rate
Pro Research Analysisby 
Searched over 200M research papers
Metoprolol and Heart Rate Reduction
Metoprolol, a beta-blocker, is widely used to lower heart rate in various cardiac conditions. Studies consistently show that metoprolol effectively reduces both resting and exercise-induced heart rates in patients with heart failure, coronary artery disease, and arrhythmias 1235+1 MORE.
Dose-Dependent Heart Rate Effects
The reduction in heart rate with metoprolol is dose-dependent. Higher doses, such as 200 mg controlled-release/extended-release (CR/XL), result in a more pronounced suppression of heart rate compared to lower doses or immediate-release formulations . This effect is observed both at rest and during exercise, with higher doses leading to greater heart rate reduction .
Heart Rate Control in Chronic Heart Failure
In patients with chronic heart failure, metoprolol significantly lowers resting heart rate over time. For example, average resting heart rate decreased from about 83 bpm to 65 bpm over 12 months of treatment, with improvements in cardiac function and motor performance 29. These benefits are seen across different age groups and doses, although psychological responses may vary by gender .
Acute Heart Rate Reduction in Myocardial Infarction and Arrhythmias
Metoprolol also reduces heart rate acutely in patients with myocardial infarction, even in those with initially low heart rates (≤65 bpm). The reduction is most pronounced immediately after intravenous administration, with good tolerance . In the emergency management of atrial fibrillation with rapid ventricular response, intravenous metoprolol achieves similar rate control compared to diltiazem, with no significant difference in the incidence of bradycardia 810.
Heart Rate Variability and Autonomic Effects
Metoprolol increases heart rate variability in patients with coronary artery disease, which is considered beneficial for cardiac autonomic control. This effect is similar to that of atenolol, another beta-blocker, and may contribute to the protective effects of beta-blockade in ischemic heart disease .
Sex and Genetic Differences in Heart Rate Response
Women may experience a stronger heart rate reduction and a higher risk of bradycardia at higher metoprolol plasma concentrations compared to men, even when given the same dose . Additionally, individuals with poor CYP2D6 metabolism (a genetic trait) have a greater reduction in heart rate and are at higher risk for bradycardia when treated with metoprolol .
Metoprolol in Hypertrophic Cardiomyopathy
In patients with obstructive hypertrophic cardiomyopathy, metoprolol lowers heart rate at rest and during exercise, and also improves stroke volume and reduces left ventricular outflow tract gradient .
Conclusion
Metoprolol consistently lowers heart rate in a variety of cardiac conditions, with effects that are dose-dependent and influenced by sex and genetic factors. It is effective for both chronic and acute heart rate control, improves heart rate variability, and is generally well-tolerated. However, individual responses may vary, highlighting the importance of personalized dosing and monitoring for bradycardia, especially in women and those with certain genetic backgrounds.
Sources and full results
Most relevant research papers on this topic